Search Results - "BREEMS, D. A"

CSF flow cytometry greatly improves diagnostic accuracy in CNS hematologic malignancies by BROMBERG, J. E. C, BREEMS, D. A, KRAAN, J, BIKKER, G, VAN DER HOLT, B, SMITT, P. Sillevis, VAN DEN BENT, M. J, VAN'T VEER, M, GRATAMA, J. W

“…To assess the diagnostic accuracy of flow cytometric immunophenotyping in comparison with classic cytomorphology for diagnosing CNS localizations of…”
Get full text

Correction: Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS by Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.

“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text

Intensive chemotherapy to improve outcome in patients with acute lymphoblastic leukemia over the age of 40: a phase II study for efficacy and feasibility by HOVON by Daenen, S, van der Holt, B, Dekker, A W, Willemze, R, Rijneveld, A W, Biemond, B J, Muus, P, van de Loosdrecht, A A, Schouten, H C, van Marwijk Kooy, M, Breems, D A, Demuynck, H, Maertens, J, Wijermans, P W, Wittebol, S, de Klerk, E W, Cornelissen, J J

Get full text

PLERIXAFOR IN POOR STEM CELL MOBILIZERS: THE BELGIAN COMPASSIONATE USE PROGRAM by Selleslag, D, Dierickx, D, Breems, DA, Huynh, P, Van De Velde, A, Meers, S, Brouwer, E, Mertens, A

“…Introduction: Currently available stem cell mobilizing regimens (G-CSF +/- chemotherapy) show high failure rates, especially in heavily pretreated patients…”
Get full text

Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells by BREEMS, D. A, BLOKLAND, E. A. W, PLOEMACHER, R. E

“…It has been reported that stroma-dependent cultures support proliferation of hematopoietic stem cells (HSC). In order to investigate the effect of soluble…”
Get full text

Stroma-conditioned medium and sufficient prestimulation improve fibronectin fragment-mediated retroviral gene transfer into human primitive mobilized peripheral blood stem cells through effects on their recovery and transduction efficiency by BREEMS, D. A, VAN DRIEL, E. M, HAWLEY, R. G, SIEBEL, K. E, PLOEMACHER, R. E

“…Mobilized peripheral blood stem cells (PBSC) are an attractive vehicle for cancer gene therapy. However these stem cells may have a reduced proliferative…”
Get full text

The role of advanced atherosclerosis in idiopathic retroperitoneal fibrosis. Analysis of nine cases by Breems, D A, Haye, H, van der Meulen, J

“…Idiopathic retroperitoneal fibrosis is an uncommon inflammatory disease characterized by a periaortic fibrous mass throughout the retroperitoneum that often…”
Get more information

Individual Stem Cell Quality in Leukapheresis Products Is Related to the Number of Mobilized Stem Cells by Breems, Dimitri A., van Hennik, Paula B., Kuşadasi, Nuray, Boudewijn, Adrie, Cornelissen, Jan J., Sonneveld, Pieter, Ploemacher, Rob E.

“…Peripheral blood stem cells (PBSC) are used for stem cell support in patients after intensive chemotherapy and generally permit faster hematopoietic recovery…”
Get full text

Frequency analysis of multidrug resistance-1 gene transfer into human primitive hematopoietic progenitor cells using the cobblestone area-forming cell assay and detection of vector-mediated P-glycoprotein expression by rhodamine-123 by Fruehauf, S, Breems, D A, Knaän-Shanzer, S, Brouwer, K B, Haas, R, Löwenberg, B, Nooter, K, Ploemacher, R E, Valerio, D, Boesen, J J

“…Transfer of the multidrug resistance-1 (MDR1) gene into hematopoietic progenitor cells may reduce myelotoxicity of MDR1-related cytotoxic agents and therefore…”
Get more information

Stroma-Contact Prevents Loss of Hematopoietic Stem Cell Quality During Ex Vivo Expansion of CD34+ Mobilized Peripheral Blood Stem Cells by Breems, Dimitri A., Blokland, Ellen A.W., Siebel, Karen E., Mayen, Angelique E.M., Engels, Lilian J.A., Ploemacher, Rob E.

“…Stroma-supported long-term cultures (LTC) allow estimation of stem cell quality by simultaneous enumeration of hematopoietic stem cell (HSC) frequencies in a…”
Get full text

Diphtheria Toxin Fused to Granulocyte-Macrophage Colony-Stimulating Factor Eliminates Acute Myeloid Leukemia Cells With the Potential to Initiate Leukemia in Immunodeficient Mice, But Spares Normal Hemopoietic Stem Cells by Terpstra, Wim, Rozemuller, Henk, Breems, Dimitri A., Rombouts, Elwin J.C., Prins, Arie, FitzGerald, David J.P., Kreitman, Robert J., Wielenga, Jenne J., Ploemacher, Rob E., Löwenberg, Bob, Hagenbeek, Anton, Martens, Anton C.M.

“…We studied the cell kill induced by granulocyte-macrophage colony-stimulating factor (GM-CSF ) fused to Diphtheria Toxin (DT-GM-CSF ) in acute myeloid leukemia…”
Get full text

Unusual immunophenotypic shift in a patient with T-cell acute lymphoblastic leukemia by van der Velden, V H J, van Lom, K, Hoogeveen, P G, Beverloo, H B, Breems, D A

Get full text

Azacitidine maintenance after intensive chemotherapy improves DFS in older AML patients by Huls, Gerwin, Chitu, Dana A., Havelange, Violaine, Jongen-Lavrencic, Mojca, van de Loosdrecht, Arjan A., Biemond, Bart J., Sinnige, Harm, Hodossy, Beata, Graux, Carlos, Kooy, Rien van Marwijk, de Weerdt, Okke, Breems, Dimitri, Klein, Saskia, Kuball, Jürgen, Deeren, Dries, Terpstra, Wim, Vekemans, Marie-Christiane, Ossenkoppele, Gert J., Vellenga, Edo, Löwenberg, Bob

“…The prevention of relapse is the major therapeutic challenge in older patients with acute myeloid leukemia (AML) who have obtained a complete remission (CR) on…”
Get full text

Comparative therapeutic value of post-remission approaches in patients with acute myeloid leukemia aged 40–60 years by Cornelissen, J J, Versluis, J, Passweg, J R, van Putten, W L J, Manz, M G, Maertens, J, Beverloo, H B, Valk, P J M, van Marwijk Kooy, M, Wijermans, P W, Schaafsma, M R, Biemond, B J, Vekemans, M-C, Breems, D A, Verdonck, L F, Fey, M F, Jongen-Lavrencic, M, Janssen, J J W M, Huls, G, Kuball, J, Pabst, T, Graux, C, Schouten, H C, Gratwohl, A, Vellenga, E, Ossenkoppele, G, Löwenberg, B

“…The preferred type of post-remission therapy (PRT) in patients with acute myeloid leukemia (AML) in first complete remission (CR1) is a subject of continued…”
Get full text

Lenalidomide added to standard intensive treatment for older patients with AML and high-risk MDS by Ossenkoppele, G. J., Breems, D. A., Stuessi, G., van Norden, Y., Bargetzi, M., Biemond, B. J., A von dem Borne, P., Chalandon, Y., Cloos, J., Deeren, D., Fehr, M., Gjertsen, B., Graux, C., Huls, G., Janssen, J. J. J. W., Jaspers, A., Jongen-Lavrencic, M., de Jongh, E., Klein, S. K., van der Klift, M., van Marwijk Kooy, M., Maertens, J., Michaux, L., van der Poel, M. W. M., van Rhenen, A., Tick, L., Valk, P., Vekemans, M. C., van der Velden, W. J. F. M., de Weerdt, O., Pabst, T., Manz, M., Löwenberg, B.

“…More effective treatment modalities are urgently needed in patients with acute myeloid leukemia (AML) of older age. We hypothesized that adding lenalidomide to…”
Get full text

Acute myeloid leukemia with monosomal karyotype at the far end of the unfavorable prognostic spectrum by Breems, Dimitri A, Löwenberg, Bob

Get full text

Stroma-supported progenitor production as a prognostic tool for graft failure following autologous stem cell transplantation by VAN HENNIK, Paula B, BREEMS, Dimitri A, KUSADASI, Nuray, SLAPER-CORTENBACH, Ineke C. M, VAN DEN BERG, Henk, VAN DER LELIE, Hans J, SCHIPPERUS, Martin R, CORNELISSEN, Jan J, PLOEMACHER, Rob E

“…To analyse the involvement of a possible numerical or qualitative stem cell defect in the development of sustained graft failure after autologous…”
Get full text

Retroviral transfer of the multidrug resistance-1 gene into lineage-committed and primitive hemopoietic cells by Fruehauf, S, Boesen, J J, Breems, D A, Höft, R, Hundsdörfer, P, Zeller, W J, Löwenberg, B, Ploemacher, R E, Haas, R, Valerio, D

“…Transfer of the multidrug resistance-1 (MDR1) gene to hemopoietic cells for myeloprotection against cytostatic agents is a new and rapidly developing field in…”
Get more information

Prognostic Index for Adult Patients With Acute Myeloid Leukemia in First Relapse by BREEMS, Dimitri A, VAN PUTTEN, Wim L. J, BOOGAERTS, Marc A, LÖWENBERG, Bob, HUIJGENS, Peter C, OSSENKOPPELE, Gert J, VERHOEF, Gregor E. G, VERDONCK, Leo F, VELLENGA, Edo, DE GREEF, Georgine E, JACKY, Emanuel, VAN DER LELIE, Johannes

“…The treatment of acute myeloid leukemia (AML) in first relapse is associated with unsatisfactory rates of complete responses that usually are short lived…”
Get full text

Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay by Breems, D A, Blokland, E A, Neben, S, Ploemacher, R E

“…Stroma-dependent long-term bone marrow cultures (LTBMC) assay the ability of primitive haematopoietic stem cells (HSC) for long-term production of clonable…”
Get more information